Literature DB >> 26593076

Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Charitharth Vivek Lal1, Namasivayam Ambalavanan2.   

Abstract

The pathogenesis of bronchopulmonary dysplasia (BPD) is multifactorial, and the clinical phenotype of BPD is extremely variable. Several clinical and laboratory biomarkers have been proposed for the early identification of infants at higher risk of BPD and for determination of prognosis of infants with a diagnosis of BPD. The authors review available literature on prediction tools and biomarkers of BPD, using clinical variables and biomarkers based on imaging, lung function measures, and measurements of various analytes in different body fluids that have been determined to be associated with BPD either in a targeted manner or by unbiased omic profiling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Bronchopulmonary dysplasia; Early diagnosis; Infant; Premature; Prognosis; Pulmonary hypertension; Systems biology

Mesh：

Substances：

Year:  2015        PMID： 26593076      PMCID： PMC4662054          DOI： 10.1016/j.clp.2015.08.004

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN： 0095-5108            Impact factor:   3.430


  99 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

3.  A genome-wide association study (GWAS) for bronchopulmonary dysplasia.

Authors:  Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich
Journal:  Pediatrics       Date:  2013-07-29       Impact factor: 7.124

Review 4.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

Review 5.  Oxidative stress in the newborn--a 30-year perspective.

Authors:  Ola Didrik Saugstad
Journal:  Biol Neonate       Date:  2005

6.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

7.  Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis.

Authors:  J D Corcoran; C C Patterson; P S Thomas; H L Halliday
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

8.  Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity.

Authors:  S Kotecha; L Wilson; A Wangoo; M Silverman; R J Shaw
Journal:  Pediatr Res       Date:  1996-08       Impact factor: 3.756

9.  Prediction of outcome from the chest radiograph appearance on day 7 of very prematurely born infants.

Authors:  Anne Greenough; Mark Thomas; Gabriel Dimitriou; Olivia Williams; Alice Johnson; Elizabeth Limb; Janet Peacock; Neil Marlow; Sandra Calvert
Journal:  Eur J Pediatr       Date:  2003-11-11       Impact factor: 3.183

10.  Bronchopulmonary dysplasia: new high resolution computed tomography scoring system and correlation between the high resolution computed tomography score and clinical severity.

Authors:  Su-Mi Shin; Woo Sun Kim; Jung-Eun Cheon; Han Suk Kim; Whal Lee; Ah Young Jung; In-One Kim; Jung Hwan Choi
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500
View more
  28 in total

1.  Searching for better animal models of BPD: a perspective.

Authors:  Namasivayam Ambalavanan; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

2.  Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort.

Authors:  A R Ballard; L H Mallett; J E Pruszynski; J B Cantey
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

3.  Exposure of neonatal mice to bromine impairs their alveolar development and lung function.

Authors:  Tamas Jilling; Changchun Ren; Aaron Yee; Saurabh Aggarwal; Brian Halloran; Namasivayam Ambalavanan; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-14       Impact factor: 5.464

4.  Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.

Authors:  Charitharth Vivek Lal; Nelida Olave; Colm Travers; Gabriel Rezonzew; Kalsang Dolma; Alexandra Simpson; Brian Halloran; Zubair Aghai; Pragnya Das; Nirmal Sharma; Xin Xu; Kristopher Genschmer; Derek Russell; Tomasz Szul; Nengjun Yi; J Edwin Blalock; Amit Gaggar; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  JCI Insight       Date:  2018-03-08

5.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

6.  Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.

Authors:  A M Kunjunju; K R Gopagondanahalli; Y Chan; A Sehgal
Journal:  J Perinatol       Date:  2017-09-07       Impact factor: 2.521

7.  Magentic Resonance Imaging Evaluation of Regional Lung Vts in Severe Neonatal Bronchopulmonary Dysplasia.

Authors:  Kara R Gouwens; Nara S Higano; Kaitlyn T Marks; Julia N Stimpfl; Erik B Hysinger; Jason C Woods; Paul S Kingma
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

8.  Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.

Authors:  Judith A Voynow; Kimberley Fisher; Mary E Sunday; Charles M Cotten; Aaron Hamvas; Karen D Hendricks-Muñoz; Brenda B Poindexter; Gloria S Pryhuber; Clement L Ren; Rita M Ryan; Jack K Sharp; Sarah P Young; Haoyue Zhang; Rachel G Greenberg; Amy H Herring; Stephanie D Davis
Journal:  Pediatr Pulmonol       Date:  2020-01-29

Review 9.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

10.  Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.

Authors:  Sanne Arjaans; Brandie D Wagner; Peter M Mourani; Erica W Mandell; Brenda B Poindexter; Rolf M F Berger; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-22       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.